Kecheng Xu

2.2k total citations
82 papers, 1.6k citations indexed

About

Kecheng Xu is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Kecheng Xu has authored 82 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 24 papers in Hepatology and 22 papers in Surgery. Recurrent topics in Kecheng Xu's work include Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Pancreatic and Hepatic Oncology Research (20 papers) and Cancer Cells and Metastasis (12 papers). Kecheng Xu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Pancreatic and Hepatic Oncology Research (20 papers) and Cancer Cells and Metastasis (12 papers). Kecheng Xu collaborates with scholars based in China, Australia and Austria. Kecheng Xu's co-authors include Lizhi Niu, Jibing Chen, Shuzhen Liang, Mao Lin, Feng Mu, Jiansheng Zuo, Lizhi Niu, Mingjie Zhang, Jialiang Li and Jianying Zeng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Kecheng Xu

82 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kecheng Xu China 23 791 438 389 312 308 82 1.6k
Lizhi Niu China 22 758 1.0× 415 0.9× 374 1.0× 268 0.9× 195 0.6× 86 1.4k
Taek‐Keun Nam South Korea 21 715 0.9× 96 0.2× 421 1.1× 197 0.6× 657 2.1× 101 1.5k
Shuji Kitahara Japan 14 707 0.9× 472 1.1× 229 0.6× 212 0.7× 131 0.4× 32 1.4k
Jarrod D. Predina United States 25 846 1.1× 449 1.0× 774 2.0× 72 0.2× 272 0.9× 68 2.1k
Susannah G. Ellsworth United States 22 1.3k 1.6× 346 0.8× 590 1.5× 77 0.2× 391 1.3× 68 1.9k
Jamie Honeychurch United Kingdom 21 1.9k 2.3× 1.4k 3.1× 639 1.6× 79 0.3× 243 0.8× 53 2.9k
Marcel Bundi Switzerland 7 602 0.8× 118 0.3× 242 0.6× 82 0.3× 251 0.8× 7 1.2k
M. Devitt United States 9 1.5k 1.9× 1.0k 2.3× 627 1.6× 66 0.2× 168 0.5× 13 2.2k
Aaron T. Wild United States 21 1.3k 1.7× 171 0.4× 654 1.7× 113 0.4× 435 1.4× 53 2.0k
Carmen Timke Germany 23 1.1k 1.4× 623 1.4× 706 1.8× 50 0.2× 356 1.2× 49 2.2k

Countries citing papers authored by Kecheng Xu

Since Specialization
Citations

This map shows the geographic impact of Kecheng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kecheng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kecheng Xu more than expected).

Fields of papers citing papers by Kecheng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kecheng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kecheng Xu. The network helps show where Kecheng Xu may publish in the future.

Co-authorship network of co-authors of Kecheng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kecheng Xu. A scholar is included among the top collaborators of Kecheng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kecheng Xu. Kecheng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Tianyu, et al.. (2022). Effect of Hydrogen Inhalation Therapy on Hearing Loss of Patients With Nasopharyngeal Carcinoma After Radiotherapy. Frontiers in Medicine. 9. 828370–828370. 9 indexed citations
3.
Chen, Jibing, et al.. (2019). Hydrogen–oxygen therapy can alleviate radiotherapy-induced hearing loss in patients with nasopharyngeal cancer. Annals of Palliative Medicine. 8(5). 746–751. 10 indexed citations
4.
Lin, Mao, Shuzhen Liang, Jian Shi, et al.. (2017). Circulating tumor cell as a biomarker for evaluating allogenic NK cell immunotherapy on stage IV non-small cell lung cancer. Immunology Letters. 191. 10–15. 36 indexed citations
5.
Xu, Yingying, Dongsheng Guo, Ge Gao, et al.. (2017). Generation of an ASGR1 homozygous mutant human embryonic stem cell line WAe001-A-6 using CRISPR/Cas9. Stem Cell Research. 22. 29–32. 2 indexed citations
6.
Guo, Dongsheng, Hai‐Kun Liu, Ge Gao, et al.. (2016). Generation of non-integrated induced pluripotent stem cells from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome. Stem Cell Research. 18. 70–72. 8 indexed citations
7.
Luo, Xiaomei, Jiannan Li, Jian Shi, et al.. (2016). The Effects of Irreversible Electroporation on the Colon in a Porcine Model. PLoS ONE. 11(12). e0167275–e0167275. 13 indexed citations
8.
Niu, Lizhi, et al.. (2014). Percutaneous Cryoablation for Liver Cancer. Journal of Clinical and Translational Hepatology. 2(3). 182–8. 41 indexed citations
9.
Zhang, Zhikai, Lizhi Niu, Jianying Zeng, et al.. (2013). Treatment of central type lung cancer by combined cryotherapy: Experiences of 47 patients. Cryobiology. 67(2). 225–229. 12 indexed citations
10.
Niu, Lizhi, Xiaohua Wang, Jianying Zeng, et al.. (2013). Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer. Cryobiology. 67(2). 235–240. 47 indexed citations
11.
Yao, Fei, Lizhi Niu, Jianying Zeng, et al.. (2013). Percutaneous cryotherapy for metastatic bladder cancer: Experience with 23 patients. Cryobiology. 68(1). 79–83. 14 indexed citations
12.
Li, Jialiang, Changming Zhang, Jibing Chen, et al.. (2013). Two Case Reports of Pilot Percutaneous Cryosurgery in Familial Multiple Endocrine Neoplasia Type 1. Pancreas. 42(2). 353–357. 13 indexed citations
13.
Zhang, Zhikai, Binghui Wu, Lizhi Niu, et al.. (2013). Combination percutaneous cryotherapy and iodine-125 seed implantation for unresectable malignant thymoma: Experience in 19 patients. Cryobiology. 67(2). 170–174. 6 indexed citations
14.
Niu, Lizhi, Jibing Chen, Lihua He, et al.. (2013). Combination Treatment With Comprehensive Cryoablation and Immunotherapy in Metastatic Pancreatic Cancer. Pancreas. 42(7). 1143–1149. 74 indexed citations
15.
Zhou, Gang, Lizhi Niu, David Kung‐Chun Chiu, Lihua He, & Kecheng Xu. (2012). Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patients. Biotechnology Letters. 34(7). 1235–1241. 31 indexed citations
16.
Mu, Feng, Lizhi Niu, Haibo Li, et al.. (2012). Percutaneous comprehensive cryoablation for metastatic hepatocellular cancer. Cryobiology. 66(1). 76–80. 16 indexed citations
17.
Niu, Lizhi, Liang Zhou, Kecheng Xu, & Feng Mu. (2012). Combination of cryosurgery and Iodine-125 seeds brachytherapy for lung cancer.. PubMed. 4(5). 504–7. 22 indexed citations
18.
Chiu, David Kung‐Chun, et al.. (2010). The experimental study for efficacy and safety of pancreatic cryosurgery. Cryobiology. 60(3). 281–286. 11 indexed citations
19.
Xu, Kecheng, Lizhi Niu, Weibing He, et al.. (2008). A pilot study on combination of cryosurgery and 125iodine seed implantation for treatment of locally advanced pancreatic cancer. World Journal of Gastroenterology. 14(10). 1603–1603. 50 indexed citations
20.
Xu, Kecheng. (2003). Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma. World Journal of Gastroenterology. 9(12). 2686–2686. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026